BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11391742)

  • 1. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease.
    van Vugt JP; Siesling S; Piet KK; Zwinderman AH; Middelkoop HA; van Hilten JJ; Roos RA
    Mov Disord; 2001 May; 16(3):481-8. PubMed ID: 11391742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradykinesia in Huntington's disease. A prospective, follow-up study.
    García Ruiz PJ; Hernández J; Cantarero S; Bartolomé M; Sánchez Bernardos V; García de Yébenez J
    J Neurol; 2002 Apr; 249(4):437-40. PubMed ID: 11967649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
    Hurelbrink CB; Lewis SJ; Barker RA
    J Neurol; 2005 Jun; 252(6):642-7. PubMed ID: 15742112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinsonism in Huntington's disease.
    Reilmann R
    Int Rev Neurobiol; 2019; 149():299-306. PubMed ID: 31779817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bradykinesia in early Huntington's disease.
    Sánchez-Pernaute R; Künig G; del Barrio Alba A; de Yébenes JG; Vontobel P; Leenders KL
    Neurology; 2000 Jan; 54(1):119-25. PubMed ID: 10636136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.
    Anil M; Mason SL; Barker RA
    J Huntingtons Dis; 2020; 9(3):275-282. PubMed ID: 32675419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypokinesia in Huntington's disease co-occurs with cognitive and global dysfunctioning.
    Reedeker N; Van Der Mast RC; Giltay EJ; Van Duijn E; Roos RA
    Mov Disord; 2010 Aug; 25(11):1612-8. PubMed ID: 20629165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinesia in Huntington's disease.
    Garcia Ruiz PJ; Gomez Tortosa E; Sanchez Bernados V; Rojo A; Fontán A; Garcia de Yebenes J
    Clin Neuropharmacol; 2000; 23(1):50-2. PubMed ID: 10682231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.
    Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW
    Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of chorea and bradykinesia in Huntington's disease.
    Berardelli A; Noth J; Thompson PD; Bollen EL; Currà A; Deuschl G; van Dijk JG; Töpper R; Schwarz M; Roos RA
    Mov Disord; 1999 May; 14(3):398-403. PubMed ID: 10348461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Locomotion disturbances in Huntington's disease].
    Delval A; Krystkowiak P
    Rev Neurol (Paris); 2010 Feb; 166(2):213-20. PubMed ID: 19604530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.
    Jacobs M; Hart EP; van Zwet EW; Bentivoglio AR; Burgunder JM; Craufurd D; Reilmann R; Saft C; Roos RA;
    J Neurol; 2016 Oct; 263(10):2080-5. PubMed ID: 27435968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reaction time and rhythm of movement in Huntington's disease.
    Martínez Pueyo A; García-Ruiz PJ; Feliz CE; Garcia Caldentey J; Del Val J; Herranz A
    J Neurol Sci; 2016 Mar; 362():115-7. PubMed ID: 26944129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired motor speech performance in Huntington's disease.
    Skodda S; Schlegel U; Hoffmann R; Saft C
    J Neural Transm (Vienna); 2014 Apr; 121(4):399-407. PubMed ID: 24221215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease.
    van Vugt JP; Stijl M; Roos RA; van Dijk JG
    Clin Neurophysiol; 2003 Feb; 114(2):295-305. PubMed ID: 12559237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.
    Gaura V; Lavisse S; Payoux P; Goldman S; Verny C; Krystkowiak P; Damier P; Supiot F; Bachoud-Levi AC; Remy P
    JAMA Neurol; 2017 Sep; 74(9):1088-1096. PubMed ID: 28672395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.